Publication | Closed Access

A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination

VaccinationVaccinologyCross-protectionVaccine DevelopmentAmino AcidsRecombinant Subunit VaccineMedicineImmunologyVaccine DesignPrecision VaccinologyVaccine ResearchRev.1 Vaccination